Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 11 1998
WASHINGTON, D.C. (February 11, 1998) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement after...
Jan 7 1998
(WASHINGTON, D.C., January 7, 1998)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 21 1997
WASHINGTON, D.C. (November 21, 1997) _ Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement...
Nov 10 1997
(WASHINGTON, DC, November 10, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 7 1997
(WASHINGTON, DC, October 7, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the House...
Jul 24 1997
(WASHINGTON, DC)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement in response to the...
Jul 22 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has been honored by the Public Relations Society of America (PRSA)/Richmond, VA chapter, for...
Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...